| Exosome-based smart drug delivery tool for cancer theranostics R Kar, R Dhar, S Mukherjee, S Nag, S Gorai, N Mukerjee, D Mukherjee, ... ACS biomaterials science & engineering 9 (2), 577-594, 2023 | 65 | 2023 |
| The emergence of metal oxide nanoparticles (NPs) as a phytomedicine: A two-facet role in plant growth, nano-toxicity and anti-phyto-microbial activity R Bhattacharjee, L Kumar, N Mukerjee, U Anand, A Dhasmana, ... Biomedicine & Pharmacotherapy 155, 113658, 2022 | 53 | 2022 |
| QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CLpro Inhibitor: GA-MLR QSAR modeling supported by molecular Docking, molecular dynamics … RD Jawarkar, RL Bakal, MEA Zaki, S Al-Hussain, A Ghosh, A Gandhi, ... Arabian Journal of Chemistry 15 (1), 103499, 2022 | 33 | 2022 |
| Dynamics of natural product Lupenone as a potential fusion inhibitor against the spike complex of novel Semliki Forest Virus MKAM Nobendu Mukerjee, Anubhab Das, Swastika Maitra, Arabinda Ghosh ... PLoS ONE 17 (2), e0263853, 2022 | 31 | 2022 |
| Target specific inhibition of protein tyrosine kinase in conjunction with cancer and SARS-COV-2 by olive nutraceuticals A Ghosh, N Mukerjee, B Sharma, A Pant, Y Kishore Mohanta, ... Frontiers in pharmacology 12, 812565, 2022 | 26 | 2022 |
| Therapeutic potential of different natural products for the treatment of Alzheimer’s Disease B Chakraborty, N Mukerjee, S Maitra, M Zehravi, D Mukherjee, A Ghosh, ... Oxidative Medicine and Cellular Longevity 2022, 2022 | 21 | 2022 |
| Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance S Hoque, R Dhar, R Kar, S Mukherjee, D Mukherjee, N Mukerjee, S Nag, ... Biomarkers 28 (2), 139-151, 2023 | 18 | 2023 |
| Recognizing novel drugs against Keap1 in Alzheimer’s disease using machine learning grounded computational studies N Mukerjee, K Al-Khafaji, S Maitra, J Suhail Wadi, P Sachdeva, A Ghosh, ... Frontiers in Molecular Neuroscience 15, 1036552, 2022 | 18 | 2022 |
| Discovery of novel HSP27 inhibitors as prospective anti-cancer agents utilizing computer-assisted therapeutic discovery approaches HI Umar, AT Ajayi, N Mukerjee, AT Aborode, MM Hasan, S Maitra, ... Cells 11 (15), 2412, 2022 | 18 | 2022 |
| Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA … RL Bakal, RD Jawarkar, JV Manwar, MS Jaiswal, A Ghosh, A Gandhi, ... Saudi Pharmaceutical Journal 30 (6), 693-710, 2022 | 18 | 2022 |
| Plant-derived exosomes: A new dimension in cancer therapy. R Dhar, N Mukerjee, D Mukherjee, A Devi, SK Jha, S Gorai Phytotherapy Research: PTR, 2023 | 17 | 2023 |
| Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease N Mukerjee, A Das, RD Jawarkar, S Maitra, P Das, MA Castrosanto, ... Frontiers in aging neuroscience 14, 878276, 2022 | 16 | 2022 |
| COVID-19 diagnostic methods in developing countries M Maniruzzaman, MM Islam, MH Ali, N Mukerjee, S Maitra, MA Kamal, ... Environmental Science and Pollution Research 29 (34), 51384-51397, 2022 | 16 | 2022 |
| Nonlinear molecular dynamics of quercetin in Gynocardia odorata and Diospyros malabarica fruits: Its mechanistic role in hepatoprotection A Ghosh, P Sarmah, H Patel, N Mukerjee, R Mishra, S Alkahtani, ... PLoS One 17 (3), e0263917, 2022 | 16 | 2022 |
| Antimalarial drug discovery against malaria parasites through haplopine modification: an advanced computational approach S Akash, G Abdelkrim, I Bayil, ME Hosen, N Mukerjee, AF Shater, ... Journal of Cellular and Molecular Medicine 27 (20), 3168-3188, 2023 | 14 | 2023 |
| Interrelation between extracellular vesicles miRNAs with chronic lung diseases R Dhar, S Mukherjee, N Mukerjee, D Mukherjee, A Devi, GM Ashraf, ... Journal of Cellular Physiology 237 (11), 4021-4036, 2022 | 14 | 2022 |
| Drug-loaded chitosan scaffolds for periodontal tissue regeneration GAN Atia, HK Shalaby, M Zehravi, MM Ghobashy, HAN Attia, Z Ahmad, ... Polymers 14 (15), 3192, 2022 | 14 | 2022 |
| Exosome‐mediated PROTACs delivery to target viral infections N Mukerjee, S Maitra, A Ghosh, V Subramaniyan, R Sharma Drug development research 84 (6), 1031-1036, 2023 | 13 | 2023 |
| Prostaglandins and non-steroidal anti-inflammatory drugs in Covid-19 HM Al-Kuraishy, AI Al-Gareeb, TJ Al-Maiahy, A Alexiou, N Mukerjee, ... Biotechnology and Genetic Engineering Reviews, 1-21, 2022 | 13 | 2022 |
| Potential therapeutic approach of melatonin against omicron and some other variants of SARS-CoV-2 R Begum, ANM Mamun-Or-Rashid, TT Lucy, MK Pramanik, BK Sil, ... Molecules 27 (20), 6934, 2022 | 12 | 2022 |
Athanasios AlexiouNovel Global Community Educational Foundation, AustraliaVerified email at ngcef.net
